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Summary.-Cr(III) and Cr(VI) compounds of varying solubilities have been tested
in vitro for their ability to inhibit cell growth and nucleic acid and protein syntheses
in BHK cells, to induce alterations in the mitotic cycle in HEp cells, and to increase
the frequency of chromosomal aberrations and sister chromatid exchanges (SCE) in
CHO cells.
All Cr(VI) compounds, and particularly those containing soluble Cr(VI), such as
potassium dichromate and zinc yellow, differentially inhibit macromolecular
syntheses in BHK cells, that of DNA being always the most affected. Among Cr(III)
compounds, which generally have very low cytotoxicity, chromite is particularly
active, and inhibits cell growth and DNA synthesis even more than the poorly
soluble Cr(VI) compounds. Preincubation in growth medium, with or without
metabolizing cell cultures, solubilizes considerable amounts of Cr(VI) from zinc
yellow and chromite, but significant amounts are also obtained from the most
insoluble Cr(VI) pigments. When BHK cells are treated with such preincubated
solutions, reduction of soluble Cr(VI) to Cr(III) by cell metabolites is seen with all
Cr(VI) compounds, accompanied by decreased cytotoxicity.
The same differences between Cr(VI) and Cr(III) compounds apply to the cytotoxic
effects on mitosis of HEp cells and the clastogenic effects on CHO cells. The activity of
chromite, the only Cr(III) pigment capable of significantly increasing the frequency
of SCE, is due to contamination with soluble Cr(VI).
In contrast to the very low cytotoxicity ofCr(III), much higher chromium levels are
detected in the cells incubated with soluble Cr(III) than with the same concentrations
of soluble Cr(VI). 50%O and75%O of chromium accumulated in the cells during treat-
ments with Cr(VI) and Cr(III) respectively remains firmly bound to the cells, even
when they are incubated for up to 48 h in normal growth medium. Chromium
accumulated in the cells after treatment with Cr(III) is most probably bound to the
cell membrane, whereas some ofthe Cr(VI) is transported through the cell membrane
and reduced in the cell nucleus.
The results of the present investigation are in agreement with those obtained with
the same Cr(VI) and Cr(III) compounds in mutagenicity assays in bacteria and
carcinogenicity tests in rodents. A re-evaluation of the mechanisms of chromium
carcinogenisis is proposed.
THE CARCINOGENIC ACTION of hexa- mann et al., 1979; Kanematsu et al., 1980;
valent chromium (Cr(Vl)) is supported by De Flora, 1981) and cytogenetic (Newbold
experimental data on animals (IARC, et al., 1979; Majone & Levis, 1979; Douglas
1980). Moreover, a correlation between et al., 1980) action has been observed in
the carcinogenic power of Cr(VI) com- different test systems. By contrast the
pounds and their cytotoxic (Levis & carcinogenicity of trivalent chromium
Majone, 1979; White et al., 1979), muta- (Cr(11J)) is still debated (Maltoni, 1976;
genic (Petrilli & De Flora, 1978a; Nest- Luckey & Venugopal, 1977; IARC, 1980)A. G. LEVIS AND F. MAJONE
and contradictory data have been also
obtained on its cytogenetic action in
cultured animal cells (Tsuda & Kato,
1977; Levis & Majone, 1979). None the
less, mutagenicity tests performed on
microbial systems with several Cr(III)
compounds were usually negative (Pet-
rilli & De Flora, 1978b; Kada et al., 1980;
De Flora, 1981).
Markedly different cytotoxic and cyto-
genetic activities of water-soluble Cr(VI),
as potassium dichromate, and Cr(III),
as chromium chloride, were shown in our
laboratory, with mammalian cell cultures,
on the basis oftheir effects on the physico-
chemical properties of nucleic acids
(Tamino & Peretta, 1980; Tamino et al.,
1981), nucleoside uptake and nucleic acid
synthesis (Levis et al., 1978a, b; Bianchi
et al., 1979, 1980), the functions ofplasma-
membrane enzymes (Luciani et al., 1979),
the cell-division cycle (Majone & Rensi,
1979), the induction of chromosome aber-
rations and sister-chromatid exchanges
(Majone & Levis, 1979). A screening ofthe
cytotoxic and clastogenic action of 11
water-soluble compounds of Cr(VI) and
Cr(III) has been also carried out (Levis &
Majone, 1979) and is extended here by
another 10 very soluble, barely soluble
andhighly insoluble compoundscontaining
Cr(VI) and Cr(III), among which are
several industrial pigments the carcino-
genicity ofwhich in the rat (Maltoni, 1976)
and mutagenicity in bacteria (Petrilli &
De Flora, 1978a, b; De Flora, 1981) have
already been established (Table I).
MATERIALS AND METHODS
Cells.-The heteroploid BHK 21 Syrian
hamster fibroblast line adapted to growth in
vitro in both monolayer and suspension, the
heteroploid HEp-2 human epithelial-like line
and the pseudodiploid CHO Chinese hamster
fibroblast line, maintained in vitro as mono-
layers, were grown in Eagle's minimal essen-
tial medium (MEM) supplemented with 10%
calf serum and routinely used as already
described (Levis et al., 1978a,b; Levis &
1Iajone, 1979).
Cell growth and labelling.-The reduction in
cell growth, based on the nucleic acid content
(DNA+RNA) of treated cultures, and the
inhibition of DNA, RNA and protein syn-
thesis, based on the incorporation of labelled
precursors, were determined, to evaluate the
cytotoxic effects ofCr compounds in BHK cell
cultures. Labelling with 2 ,uCi/ml thymidine-
6-H3 (Radiochemical Centre, Amersham,
gngland; 2 Ci/mM), uridine-5-H3 (2-5 Ci/mM)
and L-leucine-4,5-H3 (0.5-1 Ci/mM), differen-
tial extraction and determination of soluble
nucleotides and amino acids, nucleic acids
and proteins, and evaluation of the actual
ratesofmacromolecularsynthesesandchanged
uptake of soluble precursor due to Cr action,
were performed by the procedures already
described (Levis et al., 1978a,b; Levis &
Majone, 1979).
Mitotic studies.-HEp cell cultures were
grown on coverslips, fixed in Carnoy's fluid
and stained with Mayer's haemalum, as
already described (Majone & Rensi, 1979).
Three to four thousand cells were then
examined for each dose level and each time
interval, and the mitotic index (the ratio of
all mitoses to the total number of cells) and
the frequencies of each mitotic phase (the
ratios of cells in each phase to total mitoses)
were determined.
Chromosome preparations.-3 x 10-5M bro-
modeoxyuridine (Sigma, St Louis, Mo.,
U.S.A.) was incorporated for 2 cell cycles
(32 h) in CHO cell cultures, and then meta-
phase cells were prepared as detailed else-
where (Levis & Majone, 1979), so that
chromosome aberrations and sister-chromatid
exchanges (SCE) were scored on the same cell
preparations.
Chromium determinations.-Cr(VI) was de-
termined spectrophotometrically by the
direct coloured reaction with 1,5-diphenyl-
carbazide(DPCA) (RiedelDeHaen,Hannover,
West Germany), and Cr(III) by the same
reaction after oxidation to Cr(VI) with potas-
sium permanganate, as already described
(Levis et al., 1978a, b; Levis & Majone, 1979).
The colorimetric method was sensitive to
0-01 ,ug Cr(VI) per ml final solution with 5cm
spectrophotometric cells, and followed Beer's
lawup to a concentration of1 jugCr(VI) perml
final solution (or 1 pt/106). Standard calibra-
tion curves, made with potassium dichromate
and chromium chloride as highly soluble
Cr(VI) and Cr(III) salts, gave reliable results
for the direct Cr(VI) determination by
DPCA in Hanks' balanced salt solution
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(HBSS) and MEM, provided that phenol
red was not added to the solutions as an
indicator ofpH, as well as for total Cr deter-
mination (Cr(VI)+Cr(IJJ)) in HBSS, MEM
and treated cells, after wet decomposition
of the samples by mineralization at 180NC
for 2-3 h with nitric acid: sulphuric acid:
perchloric acid (3:1:1) and oxidation with
potassium permanganate. The last procedure
has been used also for Cr(VI) and Cr(III)
determination in biological samples both by
atomic absorption spectrophotometry (Feld-
man et al., 1967) and gas chromatography
(Savory et al., 1970) but in our experience it
does not allow us to estimate the original
oxidationstate ofCrinthematerial examined.
The high-temperature acidic digestion pro-
duces significant losses of Cr(VI) and an
almost complete oxidation of Cr(III) that
cannot be avoided by changing the composi-
tion of the acidic mixture. Reliable estima-
tions ofCr(VI) and Cr(III) in the treated cells
have been obtained in the present investiga-
tion by suspending the cells in water after
treatment, and precipitating them by 5%j10
(final) trichloroacetic acid. According to the
standard calibration curves carried out in this
way, Cr(VI) can be determined directly by
DPCA in the supernatant, whereas Cr(III)
can be measured after hot acidic digestion
and oxidation with potassium permanganate
ofthe whole sample.
Chromium compounds and cell treatments.-
The tested compounds of Cr(VI) and Cr(III)
and their physico-chemical properties are
listed in Table I. In many experiments in
which most of them were highly insoluble or
only partially soluble (see Tables I, IV, V),
Cr compounds were directly suspended in the
growth medium used for treatments. In the
experiments on the induction of chromosome
aberrations and SCE in CHO cells, almost
complete solubilization was obtained in N
HCI for Cr(III) compounds and 0-5N NaOH
for Cr(VI) compounds, after which they were
diluted with MEM to the final concentrations
specified in Table IX. Several treatments
were performed by pre-incubating the dif-
TABLE I.-Physico-chemical properties of chromium compounds
Oxidation
Compound*
Chromium yellow
Chromium orange
Main Cr component
Lead chromate
Basic lead chromate
state
of Cr Chemical composition (%)t
(VI) PbCrO4 (41-85); PbSO4 (4-45)
SiO2 (0 1-3); A1203 (2-6)
(VI) PbCrO4.PbO
Solubility
in water
Very low
Very low
Molybdenum orange Lead chromate
Zinc yellow Basic zinc chromate
Potassium dichromate
(VI) PbCrO4 (72-77); PbSO4 (4-6)
PbMoO4 (12-14); A1203 (2)
(VI) ZnCrO4. Zn(OH)2 (90);
CrO3 (10)
(VI) K2Cr2O7
Neochromium
Chromium alum
Chromite
Basic chromium sulphate
Chromium sulphate
Chromium oxide
Chromium sulphate
Chromium chloride
(III) Cr(OH)SO4 (56-58);
Na2SO4 (23-24); H20 (18-21)
(III) Cr2(SO4)3 (37-39);
K2SO4 (16-18); H20 (43-47)
(III) Cr2O3 (44-46); Fe2O3 (29-30);
A1203 (15-16); SiO2 (0 5-3);
CaO (05-2)
(III) Cr2(SO4)3.nH2O
(III) CrCl3. 6H20
* Potassium dichromate (Mallinckrodt, St Louis, Mo, U.S.A.), chromium sulphate (Mallinckrodt) and
chromium chloride (Merck, Darmstadt, West Germany) were analytical-grade reagents. Other compounds
were industrial pigments, kindly supplied by Dr Cesare Maltoni (Istituto di Oncologia "Felice Addarii",
Bologna, Italy), which had already been tested for carcinogenicity in the rat (Maltoni, 1976) and muta-
genicity in bacteria (Petrilli & de Flora, 1978a,b; de Flora, 1981).
t As reported by the producers (Montedison, Allessandria, Italy).
$ Up to 10-1M in water and up to 10-3M in growth medium.
Very low
Slight
Hight
Slight
Slight
Very low
Verylow
Hight
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ferent Cr compounds in MEM, with or without
BHK cell suspensions; then the cells were
discarded and the medium filtered through
Millipore filters (0-22 Hum pore size) and used
to treat BHK or HEp cell monolayers (see
Tables IV, V, VII and Fig. 3). The cytotoxic
and clastogenic effects were usually deter-
mined just at the end of Cr treatments, but
sometimes the treated cells were washed with
HBSS and incubated with normal growth
medium, so that the effects of Cr were deter-
mined at different times after the end of
treatment (see Fig. 3 and Table VII). Owing
to the approximate chemical composition
and the very different water solubilities ofthe
compounds used, treatment concentrations
are generally expressed as mg/ml ofthe whole
compound, whereas the concentrations of
Cr(VI) or Cr(III) are specified when solubil-
ized Cr amounts were determined by the
DPCA reaction.
RESULTS
Cytotoxicity of chromium on BHK cells
Typical patterns of inhibition of macro-
molecular synthesis in BHK monolayers
treated for different times with different
concentrations of soluble Cr(VI) as potas-
sium dichromate, are shown in Fig. 1, and
in Table II the results of several such
kinetic studies have been extrapolated in
order to calculate the length of treatment
giving equal inhibitions ofDNA, RNA and
protein syntheses. As already observed
(Levis et al., ]978b) Cr(VI) differentially
inhibits macromolecular syntheses, pro-
ducing a very rapid blockage of DNA
replication, whereas RNA synthesis is
reduced more slowly and only secondarily,
and protein synthesis is affected even later
and less. The cytotoxicity is more marked
when the cells are treated in HBSS, in
which Cr(VI) reduction by the extra-
cellular components is minimal.
The action of Cr(VI) and Cr(III) com-
pounds on growth and macromolecular
syntheses of BHK cells is shown in Table
III. In this experiment different concen-
trations of Cr compounds were added
directly to the growth medium of cell
suspensions, and their effects were deter-
mined 48 h later. The concentrations used
were 0 5, 0.15 and 0 05 mg/ml of Cr(VI)
compounds and only 0 5 mg/ml for Cr(III)
compounds, on account of the already
observed much lower cytotoxicity of
Cr(III) (Levis etal., 1978a; Levis&Majone,
1979). Exposure to all the concentrations
of potassium dichromate and zinc yellow,
as well as to 0 5 mg/ml of Cr orange,
produces the maximum cytotoxicity of
Cr(VI) treatments, all the cells beingkilled,
whereas the same effect is produced only
by exposure to 0 5 mg/ml of chromite,
of the Cr(III) compounds (Table III).
Treatments with 0*15 mglml of Cr yellow
and molybdenum orange significantly
inhibit cell growth and macromolecular
syntheses, whereas neochromium, Cr alum
and Cr sulphate produce comparable
inhibition at a higher concentration (0.5
mg/ml). On the other hand Cr chloride,
though the only completely soluble Cr(III)
compound, has no cytotoxicity. DNA
synthesis is the most sensitive to all
Cr compounds, RNA andprotein syntheses
being always less inhibited.
As most ofthe compounds were scarcely
soluble or even highly insoluble in water,
preincubation for 48 h in MEM with BHK
cell suspensions or in MEM without cells
was carried out, to facilitate solubilization
of Cr(VI) and complex formation between
Cr(III) and medium components or cell
metabolites. At the end of preincubation,
the cells were discarded and the solubilized
Cr(VI) and Cr(III) contents were deter-
mined in the filtered MEM, which was
then used to treat fresh BHK monolayers
for 2 h. Table IV shows the effects of
preincubated Cr compounds on macro-
molecular syntheses, and the amounts of
Cr(VI) and Cr(III) solubilized in MEM in
the treatments. Among Cr(VI) compounds,
potassium dichromate and zinc yellow
again display the highest cytotoxicity,
as they markedly inhibit DNA synthesis
even when preincubated at 0 05 mg/ml.
Moreover their inhibitory effects are more
marked when preincubation is made in
cell-free MEM. Among Cr(III) compounds,
chromite is the most powerful, as it sig-
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FIa. 1.-Effects of Cr(VI), as potassium dichromate, on macromolecular syntheses in BHK cell
cultures. BHK monolayers were treated for different times with 1 ,g/ml (LC), 10 ,ug/ml ( 0, 0) and
100 ug/ml]( A) in MEM (closed symbols) or HBSS (open symbols). The actual rates of DNA (A),
RNA (B) and protein (C) syntheses were determined by labelling for 1 h with tritiated precursors
just at the end of treatment.
TABLE II.-Effects of Cr(VI), aS potassium
dichromate, on macromolecular syntheses
in BHK monolayers
K2Cr2O7 Macro-
treatment for molecular
various times synthesis*
100 ,ug/ml in MEM
10 ,ug/ml in HBSS
10 ,ug/ml in MEM
Length oftreatment (h)
giving comparable
inhibitiont
50% > 90%
DNA < 0-25
RNA 0 75-1-0
Proteins 1-3
DNA 0-25-0-5
RNA 1-2
Proteins 3-5
DNA 0.5-1.0
RNA 2-4
Proteins 5-9
< 0-75
5-7
6-10
2-3
6-7
8-10
2-3
>10
> 10
* The actual rates of syntheses were calculated by
labelling for 1 h with tritiated precursors just at the
end oftreatment.
t Calculated by extrapolation of macromolecular
synthesis-inhibition kinetics (Fig. 1). The range in 4
separate experiments is given.
nificantly inhibits DNA and RNA, but
not protein synthesis. The other Cr(VI)
and Cr(III) compounds, however, are
scarcely active even at 0.5 mg/ml, as they
partially inhibit nucleic acid synthesis
only when preincubated in cell-free MEM,
with the exception of CrCl3 which is
completely inactive throughout.
Concerning theamounts ofCrsolubilized
during preincubation, it can be observed
(Table IV) that potassium dichromate
and CrCl3 are completely soluble in
MEM; 0-5 mg/ml of these compounds
correspond to 176.9 p,g/ml of Cr(VI) and
97-7 ,g/ml of Cr(I11) respectively, which
are very close to the observed values.
Partial solubilization ofCr(III) is obtained
with neochromium and Cr alum, whereas
preincubation of the other compounds
gives very low levels of soluble Cr. Among
VI
0
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TABLE III.-Cytotoxic effects of Cr compounds in BHK monolayers
Treatment
(48 h in MEM)
Chromium yellow (VI)
Chromium orange (VI)
Molybdenum orange (VI)
Zinc yellow (VI)
Potassium dichromate (VI)
Neochromium (III)
Chromium alum (III)
Chromite (III)
Chromium sulphate (III)
Chromium chloride (III)
Cell
Concen- growth
tration (% of
(mg/ml) controls)*
0-5
0-15
0-05
0.5
0-15
0-05
0-5
0-15
0-05
0-5/0-15/0-05
0-5/0-15/0-05
0-5
0-5
0-5
0-5
0-5
65
86
100
0
41
72
48
72
92
0
0
75
88
0
68
100
Macromolecular syntheses
t A A
(% ofcontrols)t
DNA RNA Proteins
14
65
86
0
11
43
15
52
75
0
0
48
66
0
45
100
45
87
90
0
53
84
34
65
76
0
0
69
89
0
55
100
83
100
100
0
75
92
56
100
100
0
0
88
96
0
69
100
* Estimated as DNA+RNA content of cultures.
t Estimated by incubation for 1 h with labelled precursors just at the end of treatment.
TABLE IV.-Cytotoxic effects of Cr compounds in BHK monolayers (cont.)
Treatment*
Chromium yellow (VI)
Chromium orange (VI)
Molybdenum orange (VI)
Zinc yellow (VI)
Potassium dichromate (VI)
Neochromium (III)
Chromium alum (III)
Chromite (III)
Chromium sulphate (III)
Chromium chloride (III)
Chromium solubilized
Macromolecular syntheses (tg/ml) at end of
(% ofcontrols)t preincubation
Concen- -___ A_ _
tration Preinc. in In
during Preinc. in MEM MEM+BHK In MEM MEM+BHK
preincu- I_ A_ --) I
' -% (( A
bation Pro- Pro- Cr Cr Cr Cr
(mg/ml) DNA RNA teins DNA RNA teins (VI) (III) (VI) (III)
0-5 40
0-15/0-05 100
0-5 62
0-15/0-05 100
0-5 74
0-15/0-05 100
0-5 3
0-15 3
0-05 36
0-5 4
0-15 4
0-05 24
0-5 85
0-5 92
0-5 53
0-5 82
0-5 100
59 72
100 100
93 100
100 100
81 100
100 100
17 24
26 47
94 100
39 52
42 68
90 100
93 100
100 100
84 100
87 100
100 100
100 100
100 100
100 100
100 100
100 100
100 100
4 25
4 42
52 100
7 49
16 64
35 100
100 100
100 100
68 96
100 100
100 100
100
100
100
100
100
100
40
62
100
69
100
100
100
100
100
100
100
3-8 0-8 0-2 3-1
2-7 0-4 0-0 3-5
3-4 1-7 0-3 4-7
6-9 1-1 2-8 15-8
166-2 17-1 134-0 45-5
0-0 35-2 0-0 48-0
0-0 38-3 0-0 48-5
5-3 1-1 1-6 11 1
0-0 2-8 0-0 3-1
0-0 111-9 0-0 114-3
* Cells exposed for 24 h to growth medium preincubated for 48 h with different concentrations of Cr
compounds.
t Estimated as in Table III.
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TABLE V. Cytotoxic effects of Cr(VI), as zinc yellow and chromium orange, in BHK
monolayers
Treatment,*
(0(5 mg/ml)
Zinc yellow (VI)
Chlromitum orange (VI)
Alaeromolecular synthleses, (0% of controls)
Preinc. in
Preine. in MEM
A
Preineu- Pro-
bationi DNA RNA teins
21i 10 54 79
1 (1 8 40 62
2 (I 4 19 37
3dl 4 12 32
6cl 1 9 25
2 100 100 100
1 (I 84 100 100
2 d 54 85 92
3 d 47 81 100
2 d 21 66 78
MAIEM + BHK
Pro-
DNA RNA teins
21 64 100
16 49 94
6 28 62
5 20 56
2 17 41
100 100 100
95 100 100
86 96 100
78 100 100
52 72 92
Chromium solubilized
(,ug/ml) at end of
preincubation
In
In MEMI AIEM + BHK
Cr Cr Cr Cr
(VI) (III) (VI) (III)
6-1 0-6 0-2 9-3
4-8 0 3 1-7 8-8
62- 05 1-7 12-2
6-9 09 1-8 15-8
0-5
0-9
0-9
1-1
0-2
0-4
0-6
0-5
0-0
0-0
0-2
0-2
2-1
2-8
3-2
3-9
* Mlonolayers wvere exposed for 24 hi to preincubated growtlh medlitum.
the water-insoluble Cr compounds, zinc
yellow and chromite give the highest
solubilized chromium levels, particularly
when preincubated with BHK cells. As a
general rule, preincubation of Cr(VI)
compounds in cell-free MEM solubilizes
greater amounts of Cr(VI), whereas pre-
incubation in MEM with cells is accom-
panied by almost complete reduction of
solubilized Cr(VI) to Cr(III). It must be
stressed that, among Cr(III) compounds,
only preincubation of chromite gives, on
solubilization, significant amounts of
Cr(VI), obviously derived from impurities
in the chromite.
The cytotoxic effects of the 2 poorly
soluble Cr(VI) compounds, zinc yellow
and Cr orange, have been determined in
BHK monolayers after different durations
of preincubation in MEM, with or without
cell suspensions (Table V). Zinc yellow
strongly inhibits nucleic acid synthesis
even after 2h preincubation, and its cyto-
toxicity increases with longer preincuba-
tions. Cr orange is much less active,
giving considerable inhibition of nucleic
acid synthesis only after 6 days of pre-
incubation. Again the cytotoxicity is
greater after preincubation in cell-free
MEM than in MEM with cells. An increas-
ing amount of Cr(VI) is solubilized with
increasing preincubation time inMEM, and
is reduced to Cr(III) in the presence of
cells. It appears also in Table V that pre-
incubation in MEM with cells gives more
solubilized total Cr than preincubation
in MEM alone, which is an almost general
rule for all Cr compounds used (see Table
IV).
Chromium accumulation and stability in
BHK cells
The accumulation of Cr in BiHK cell
suspensions was determined after exposure
for up to 6 h to the very soluble Cr(VI)
and Cr(II) compounds potassium di-
chromate and CrCl3 (Fig. 2). Even after
6h incubation with 100 ,ug/ml of Cr(VI),
significant amounts of oxidized Cr cannot
be detected by direct reaction with DPCA
in the treated cells. On the contrary, in-
creasing amounts of Cr(III) are accumu-
lated in the cells with increasing incuba-
tion times, and with increasing treatment
concentrations of Cr(VI) or Cr(III). The
amounts of cell-linked Cr are much higher
when treatment with Cr(VI) is made in
MEM than in HBSS, whereas just the
opposite is true for treatments with
Cr(III). Moreover, much more Cr is accu-
mulated in cells incubated with Cr(11J)
than with the same concentrations of
Cr(VI).
A considerable fraction of the Cr
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FIG. 2. Accumulation of Cr(III) in BHK cell cultures. Cr(III) amounts in cell suspensions were
determinedafterdifferentlengths of treatmentwith 1 jig/ml in HBSS (Ci), 10fig/ml in HBSS( 0) or
MEM (0*) and 100,ug/ml in HBSS (A) or MEM (A) of Cr(VI) as potassium dichromate (A), or Cr(III)
as CrCl3 (B). Chromium amounts are expressed as ,ug of Cr(III) per 102 ,ug of DNA, corresponding
to 107 BHK cells suspended in 20 ml of medium.
TABLE VI.-Stability of Cr(III) accumulated in BHK cells
Treatment*
Potassium
dichromate (VI)
(100 ,tg/ml)
Incubation time (h)t
Fraction 0 12 24 36 48
Growth medium - 1-5 1-7 1-3 2-0
Cells 3-1 1-4 1-6 1-6 1-5
Total 3-1 2-9 3-3 2-9 3-5
Chromium
chloride (III)
(10 ,ug/ml)
Growth medium
Cells 33-3
Total
70 8-8 6-0 9-4
26-1 19-0 29-2 22-5
33-3 33-1 27-8 35-2 35-2
* Cell suspensions were treated for 6 h in MEM, then washed with HBSS and incubated in normal growth
medium.
t Chromium levels are expressed as ,tg of Cr(III) per 10 pg of DNA (corresponding to 107 BHK cells,
suspended in 20 ml of growth medium).
accumulated in BHK cells during a 6h
treatment with Cr(VI) or Cr(III) remains
firmly bound to the cells, even when they
are washed and re-incubated for up to
48h in normal growth medium (Table VI).
This fraction is about 50 or 75% of the
Cr accumulated in the cells during treat-
ment with Cr(VI) or Cr(III), respectively.
Cytotoxicity ofchromium in HEp cells
The cytotoxicity of Cr on mitosis of
HEp cells has been determined by treat-
ment with MEM preincubated for different
times with Cr(VI) and Cr(III) compounds.
Fig. 3 shows the effects of zinc yellow:
the percentage of total mitoses decreases
after treatment, the more markedly and
rapidly the longer the preincubation,
indicating that mitotic inhibition is pro-
duced by the solubilized Cr. On the other
hand the frequencies of abnormal pro-
phases and metaphases are increased just
0
5-
z
In
14- 4- 0
- 3 -
u
%.-. 2-
0)
1-
B
0 0
0
0
. -.
I - ..107=
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A
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FIG. 3. Effects of Cr(VI), as zinc yellow, on
mitosis ofHEp cells. The frequencies oftotal
mitoses (A), and abnormal prophases (B)
and metaphases (C) have been determined
at different intervals of time after HEp
monolayers lhad been exposed for 2 h to
growth medium preincubated for 1 (0),
2 (0), 3 (A) or 6 (A) days with 0 5 mg/ml
of zinc yellow, in the presence of BHK cell
suispensions.
after treatment and fall later, showing
that, besides late mitotic inhibition, block-
age of the cell cycle during mitosis is also
produced. As summarized in Table VII,
the differential cytotoxicity of the tested
Cr compounds on growth and macro-
molecular syntheses of BHK cells (see
above) very closely parallels their effect
on HEp cells.
Clastogenic effects of chromium in CHO
cells
The frequencies of chromosome aberra-
tions and SCE have been determined in
CHO cells after incubation for 2 division
cycles with different concentrations of
Cr compounds added directly to thegrowth
medium (Table VIII). The mean number
of chromosome aberrations is significantly
increased after treatment with all Cr(VI)
compounds, being 2-3 times the control
values after exposure to 5-25 Hug/ml of the
insoluble or poorly soluble Cr(VI) pig-
ments and 0-1 pg/ml water-soluble Cr(VI)
as potassium dichromate (0.3 Htg/ml of
salt) an increase of the same order as
that found with the same concentration
of other soluble Cr(VI) salts (Levis &
Majone, 1979). Treatment with 150 pg/ml
Cr(V7I) pigments did not permit the
analysis of chromosome aberrations, be-
cause of the marked inhibition of cell
growth and the severe delay ofthe mitotic
cycle. The frequency of chromosome aber-
rations is also increased after treatment
with Cr(III) compounds, being about
doubled after exposure to 25-150 ,tg/ml.
On the other hand, the frequencies of
SCE are significantly increased by all
Cr(VI) compounds and by chromite, but
not by the other Cr(III) compounds. The
increase is ofthe same order as thatalready
obtained with other Cr(VI) salts, and it is
much lower than that induced by mito-
mycin C, which was the positive control
for the response of our cell system to the
induction of chromosome damage (Levis
& Majone, 1979).
In a parallel experiment, CHO cells
have been exposed to Cr(VI) and Cr(III)
compounds previously solubilized with
HCI and NaOH and then diluted in the
medium used for treatments. It can be
seen (Table IX) that Cr(VI) compounds
induce chromosome aberrations at the
same concentration of water-soluble
Cr(VI) (i.e. 0-1-0-3 ,ug/ml) provided that
they are solubilized with NaOH. Cr(III)
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TABLE VII.-Effects of Cr compounds on mitosis ofHEp cells
Caryo-
Mitotic inhibition logical
______A Mitotic altera-
Treatment* Earlyt Latex block§ tionsil
Chromium yellow (VI)
Chromium orange (VI)
Molybdenum orange (VI)
Zinc yellow (VI)
Potassium dichromate (VI)
Neochromium (III)
Chromium alum (III)
Chromite (III)
Chromium sulphate (III)
Chromium chloride (III)
++ +++ ++ +
++ +++ ++ +
++ +++
+++ +++
+++ +++
_ +
+ +
++ +
+++ ~+
+++ ~+
_ +
+ +
++ +++ ++ +
+ +
+ +
++ +
+ +
* Cell monolayers were exposed for 2 h to growth medium preincubated for 2 days with 0-5 mg/ml of Cr
compounds in the presence of BHK cell suspensions.
t % Reduction ofnormalprophases at the end oftreatment: + + + (>70%); + + (30-70%); + (< 30%);
-(nil).
t % Reduction of normal prophases 24 h after treatment.
§ % Increase of abnormal metaphases 2-4 h after treatment: + + + (> 100%); + + (50-100%);
+ (<50%); - (nil).
ll Mainly chromosome bridges at anaphase; micronuclei and multinucleated cells at interphase; sticky,
lagging and pulverized chromosomes at metaphase. Details as in Tables VII-VIII.
TABLE VIII.-Chromosome aberrations and sister chromatid exchanges induced by Cr(VI)
and Cr(III) compounds in CHO cell cultures
Treatment*
Chromium yellow (VI)
Chromium orange (VI)
Molybdenum orange (VI)
Zinc yellow (VI)
Potassium dichromate (VI)
Neochromium (III)
Chromium alum (III)
Chromite (III)
Chromium sulphate (III)
Chromium chloride (III)
Concen-
trations
(Kg/ml)
5
25
150
5
25
150
5
25
150
5
25
150
0-3
5
25
150
5
25
150
5
25
150
5
25
150
50
Cell
growtht
(% control)
100
85
78
48
100
93
56
100
100
85
73
29
10
83
100
100
100
100
100
100
100
100
88
100
100
93
95
Meta-
phases
counted:
61
95
40
75
30
50
45
25
14
64
30
30
30
40
40
28
65
62
40
40
60
34
Chromo-
some and
chrom-
atid aber-
rations
per 100 SCE/
metaphases metaphase
13-3 7-47+0 11
29-2 9-34+0-19
22-5 9-90+ 0-29
25-0 9-36 + 0-25
26-7 10-47 +0-29
20-0 10-48 + 0-38
24-4 10-11 + 0-36
26-0 9-76 + 0-13
28-6 13-14+ 1-10
32-5 12-84+ 0-51
20-0 7-46 + 0-22
23-3 757+0-18
26-7 7-62+ 0-22
15-0 7-21 + 0-18
20-0 7-40+ 0-20
28-6 7-53 + 0-31
26-5 9 49+0-31
23-4 8-27+ 0-30
10-0 7-10+0-17
22-5 7-45 + 0-27
25-0 7-73 + 0 35
29-4 7-20 + 0-41
t for
SCE/
meta-
phase§
7-42
9-11
6-50
11-66
8-33
8-01
12-28
10-11
10-08
0-05
0-50
0-69
1-25
0-34
0-23
6-02
2-52
1-80
0-79
0-72
0-81
p
< 0-001
< 0-001
<0-001
< 0-001
< 0-001
< 0-001
<0-001
< 0-001
<0-001
> 0-7
>0-5
>0-4
>0-2
> 0-7
> 0-7
< 0-001
< 0-02
>0-05
>0-4
>0-4
>0-4
* Monolayers were treated for 32 h in MEM.
t Cell growth was estimated on the basis of the DNA+RNA content of treated cultures.
+ Chromosome aberrations and SCE were scored on the same 2nd division metaphases.
§ t values for comparison with control.
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TABLE IX. Chromosome aberrations and sister chromatid exchanges induced by Cr(VI)
and Cr(III) compounds in CHO cell cultures
Treatment*
HCI
NaOH
Chromium yellow (VI)
Chromiuim orange (VI)
Molybdenum orange (VI)
Zinc yellow (VI)
Potassium (liehromate (VI)
Neoehromium (III)
Clhromitum alum (III)
Chromite (III)
Chromium sulphate (III)
Chromitum chlor-ide (111)
Concen-
tration
( tg/ml)
0-Olx
0-025N
0-005N
0-015S
0-1
0-3
0-1
0-3
0-1
0-3
0-1
0-3
0-1
0-3
10
25
10
25
10
25
10
25
10
25
Meta-
phases
countedt
50
40
45
30
40
15
20
40
40
40
38
40
30
46
30
40
40
47
40
33
40
40
40
50
40
Chromo-
some and
chrom-
atid aber-
rations
per 100 SCE/
metaphases metaphase
10-0 7-54 + 0-16
10-0 7-43+0-18
10-0 7-71 +0-19
10-0 6-87 + 0-13
12-5 7-81 + 0-23
26-6 8-53+0-24
20-0 8-85 + 0-28
15-0 9-12 + 0-21
15-0 9-35 + 0-24
15-0 9-12+0-22
15-0 9-89 + 0-27
12-5 9-25 + 0-28
19-9 9-17 + 0-36
15-2 10-26 + 0 35
23-3 11-10 + 0-60
12-5 7-37 + 0-16
10-0 7-42 + 0-16
7-5 7-13+0-14
12-5 7-24 + 0-17
17-5 8-81 + 0-22
15-0 9-60+0-21
10-0 6-68+0-16
10-0 7-30 + 0-15
12-5 6-86 + 0-28
10-0 7-52 + 0-26
* Monolayers were treated for 32 h with Cr compounds previously dissolved in HCI (for Cr(III)) or NaOH
(for Cr(IV)) and then diluted in MEM (final concentrations ofHCI in MEM: 0-010-0-025; NaOH: 0-005-0 015N).
t Chromosome aberrations and sister chromatid exchanges were scored in the same 2nd division meta-
phases.
t t values for comparison witli controls treated eitlher witli HCI (0-010N, 0-025N) or NaOH (0-005N, 0-015N).
compounds solubilized with HCI and
used at the concentrations of 10-25 Htg/ml
are inactive, with the exception of chro-
mite, which significantly increases the
frequency of chromosome aberrations. It
is confirmed that the frequency of SCE is
increased by the exposure to all Cr(VI)
compounds and chromite, but not to the
other Cr(III) compounds.
DISCUSSION
According to the International Agency
for Research on Cancer (1980) there is
"sufficient" evidence for the carcino-
genicity of several Cr(VI) compounds in
the rat, whereas data from experiments
with Cr(III) compounds are considered
still inadequate for the evaluation of their
carcinogenicity. Moreover "sufficient" evi-
dence for a high risk of lung cancer in
workers engaged in the production of
chromates (Cr(VI)) is also recognized by
the IARC, though the true carcinogenic
agents cannot be identified, as the epi-
demiological data do not allow the
evaluation of the relative contribution
to the carcinogenic risk of Cr(III) or
Cr(VI) forms, both present in chromate
production.
Concerning the mutagenic power of Cr
compounds, several Cr(VI) salts have
t for
SCE/
meta-
plhasel
6-50
2-70
6-92
3-39
8-20
5-87
6-85
3-39
7-60
5-60
0-25
1-13
1-33
1-72
4-80
6-64
1-15
1-64
1-62
0-65
p
<0-001
< 0-01
<0-001
< 0-01
<0-001
< 0-001
<0-001
< 0-01
< 0-001
< 0-001
>0-7
> 0-2
>0-1
>0-1
<0-001
<0-001
> 0-2
> 0-2
>0-1
> 0-5
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been shown to be active in different test
systems in vitro and in vivo, as they are
capable of inducing errors of nucleotide
incorporation in the course of in vitro
DNA replication (Sirover & Loeb, 1976;
Tkeshelashvili et al., 1980), point muta-
tions in bacteria (Venitt & Levy, 1974;
Nishioka, 1975; Green et al., 1976;
Petrilli & De Flora, 1978b; Lofroth, 1978;
Nakamuro et al., 1978; Nestmann et al.,
1979; Kada et al., 1980; Kanematsu
et al., 1980; De Flora, 1981), yeast
(Bonatti et al., 1976) and mammalian
cells (Newbold et al., 1-979); and gene
conversion (Bonatti et al., 1976) and mito-
tic reconmbination (Nestmann et al., 1979)
in yeasts; chromosomal aberrations (Tsuda
& Kato, 1977; Nakamuro et al., 1978;
Newbold et al., 1979; Umeda & Nishimura,
1979; Levis & Majone, 1979; Douglas
et al., 1980); SCE (Levis & Majone, 1979;
Majone & Rensi, 1979; Majone & Levis,
1979; MacRae et al., 1979; Douglas et al.,
1980); DNA damage (Whiting et al.,
1979; Tamino & Peretta, 1980; Douglas
et al., 1980; Tamino et al., 1981); DNA
repair synthesis (Whiting et al., 1979);
morphological transformation (Fradkin
et al., 1975; Tsuda & Kato, 1977; Di Paolo
& Casto, 1979) and enhancement of viral
transformation (Casto et al., 1979) in
cultured mammalian cells; increased fre-
quency of micronuclei and chromosomal
aberrations in cells of rodents treated in
vivo (Wild, 1978) as well as in lymphocytes
of professionally exposed workers (Biga-
liev et al., 1977). Cr(VI) compounds gave
positive results in the mouse "spot" test
(Knudsen, 1980) and transformed Syrian
hamster cells when injected into pregnant
hamsters (Di Paolo & Casto, 1979), thus
indicating that they are also transplacen-
tal mutagens. When tested for their
ability to induce cytotoxic (White et al.,
1979) and mutagenic effects (Petrilli &
De Flora, 1978a; Koshi, 1979; Knudsen,
1980; Stern, 1980; De Flora, 1981),
industrial pigments and welding fumes
from Cr-using processes have been shown
to be uniquely active, owingtothepresence
ofCr(VI).
On the contrary, Cr(III) salts are usually
inactive in mutagenicity tests (Venitt &
Levy, 1974; Nishioka, 1975; Petrilli &
De Flora, 1978b; Kada et al., 1980;
Kanematsu et al., 1980; De Flora, 1981)
except in systems involving a direct
interaction with DNA purified in vitro,
such as damage shown by the alteration
ofits physico-chemical properties (Tamino
& Peretta, 1980; Tamino et al., 1981) and
increased error frequency during replica-
tion (Sirover & Loeb, 1976; Tkeshelashvili
1980). The only frequent cytogenetic
effect in mammalian cells treated in vitro
with Cr(III) compounds is the increase of
chromosome aberrations (Nakamuro et al.,
1978; Levis & Mlajone, 1979; see also the
present data), but it is obtained with
doses much higher than the active Cr(VI)
concentrations, and could be related to
an indirect effect produced by such ex-
treme conditions, e.g. by the release of
lysosomal nucleases. Moreover, it is found
in cell lines permanently adapted togrowth
in vitro,whichare characterizedbychromo-
somal instability. Toxicity data in animals
(IARC, 1980) and cytotoxicity studies in
cultured mammalian cells (Levis & Majone,
1979; White et al., 1979; see also the pre-
sent results) accordingly show that Cr(VI)
is 100 or even 1000 times more active than
Cr(III).
On this basis, the cytotoxic, mutagenic
and carcinogenic effects of Cr have been
attributed to its oxidized state (Levis et
al., 1978a, b; Norseth, 1979; Bianchi et al.,
1979; Langard, 1980; Petrilli & De Flora,
1 980; Leonard & Lauwerys, 1980). The
positive mutagenicity occasionally ob-
tained with Cr(III) compounds (Naka-
muro et al., 1978) cannot be related to
conversion of Cr(III) to the active Cr(VI)
form, which was described in plant cells
(Skeffington et al., 1976), but which is
generally deemed not to take place in
animal systems (Mertz, 1969; Norseth,
1979; Langard, 1980; Leonard& Lauwerys,
1980). The shift of Cr(III) to Cr(VI) was
shown not to occur in vitro with different
metabolic systems, and was obtained
only by treating with a strong oxidizing
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agent such as potassium permanganate
(Petrilli & De Flora, 1978b), so it does not
appear to be reproducible by biological
factors, at least in short-term in vitro
assays. Contamination with Cr(VI) has
been demonstrated for Cr(III) industrial
compounds (Petrilli & De Flora, 1978b;
see also the present data on chromite
contamination) and even for reagent-
gradelaboratoryproducts (Levis &Majone,
1979), which accounts for the genetic
activity observed with those agents; the
actual oxidation state of Cr in the com-
pounds used in the carcinogenicity and
mutagenicity tests is rarely checked. The
conversion of Cr(III) to Cr(VI) in the
organism has been postulated by Grogan
(1957) but it should be a slow process,
occurring only under particular conditions
of retention and accumulation of the
metal, and only in tissues with a very low
reducing potential (Petrilli & De Flora,
1978b). This could account for the car-
cinogenic action exerted at the implant
site by Cr(III) compounds administered
i.m. or s.c. (Maltoni, 1976; IARC, 1980).
The results of the present investigation
confirm the marked differences in cyto-
toxic and cytogenetic activity of Cr(VI)
and Cr(III) which we had already noticed
on treating mammalian cell cultures with
water-soluble Cr compounds (Levis et al.,
1978b; Levis & Majone, 1979; Majone &
Rensi, 1979; Luciani et al., 1979; Bianchi
et al., 1980) and can contribute to a better
understanding of the mechanisms of Cr
carcinogenic action.
The mutagenic action of the com-
pounds used in the present investigation
has been determined in the Salmonella/
microsome test by Petrilli & De Flora
(1978a,b) and De Flora (1981), who
showed that, among Cr(VI) pigments,
partially soluble zinc yellow acted as a
mutagen in the plate test at the same dose
range as very soluble sodium dichromate
and potassium chromate, and poorly
soluble Cr orange and molybdenum orange
were mutagens in the spot test, whereas
Cr yellow displayed neither mutagenic nor
toxic activity, owing to its complete
16
insolubility in water. Cr orange, molyb-
denum orange and Cr yellow, as well as
pure reagent-grade lead chromate, how-
ever, were positive in the plate test when
dissolved in 0.5N NaOH. In the same
studies, all Cr(III) compounds were in-
active as mutagens except chromite,
which was positive in the spot test owing
to contamination with traces of soluble
Cr(VI). Carcinogenicity tests have been
performed with the same industrial pro-
ducts by Maltoni (1976), who injected
them s.c. into rats. Insoluble Cr(VI) pig-
ments, namely Cr yellow, Cr orange and
molybdenum orange, raised the frequency
of sarcomas at the site of injection from
0% in the controls to 65-90%, whereas
Cr(IIJ) pigments neochromium and Cr
alum produced lower but significant in-
creases (20-25%). The same chromite
that was cytotoxic and clastogenic in the
present study and mutagenic in the study
of Petrilli & De Flora (1978b) owing to
traces of Cr(VI), failed to induce tumours
in any ofthe 40 animals tested by Maltoni
(1976) but, as in the case of zinc yellow,
necrosis was produced at the site of injec-
tion (Maltoni, personal communication),
most probably due to the oxidizing action
of soluble Cr(VI) in the administered
compounds.
In contrast to the low cytotoxicity of
Cr(III), much higher Cr levels are detected
in the cells incubated with Cr(III) than
with the same Cr(VI) concentrations (Fig.
2). As for treatments with Cr(VI), the
amounts of cell-linked Cr are higher when
the incubation is made in MEM than in
HBSS, because greater amounts of Cr(III)
are produced in MEM by the reduction of
Cr(VI) by components of the growth
medium (Levis et al., 1978b). The opposite
is found for incubations with Cr(III) (Fig.
2), probably because ligand formation
with cell constituents is more limited for
Cr(III) complexes involving MEM com-
ponents than forCr(III) chelates andolates
present in the simplified HBSS solution
(Mertz, 1969).
The different biological activities of
Cr(VI) and Cr(III) are certainly related
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to a marked difference in Cr uptake
through the cell membrane, very active
mechanisms for Cr(VI) transport having
been demonstrated, which are accom-
plished by specific chromate-ion permeases
(Vallee, 1969), whereas the transport of
Cr(III) complexes and chelatesisextremely
limited (Mertz, 1969; Norseth, 1979;
Langard, 1980). A very rapid accumula-
tion ofCr(III), even much faster than that
of Cr(VI), was described in plant root
cells (Skeffington et al., 1976), where it
was shown that most of the absorbed
Cr(VI) was in the soluble fraction, while
most of the Cr(III) was in the insoluble
membrane fraction, as in the present
experiments (see Fig. 2 and Table VI). A
multiplicity of cation-binding sites in the
cell walls and cell membrane could adsorb
Cr(III), which may explain why it is less
toxic and transported less than Cr(VI)
inside the cell, though more readily
accumulated on the cell surface. The
present experiments (Table VI) indicate
that a considerable fraction of Cr(III)
(50% or 75% of Cr accumulated in the
cells during treatment with Cr(VI) or
Cr(III) respectively), -remains firmly
bound to the cells even when they are
incubated for up to 48 h in normal growth
medium.
Whereas the cytotoxic action of Cr(VI)
has been attributed to the oxidation of
biological targets placed mainly on the
cell membrane (Levis et al., 1978a,b;
Bianchi et al., 1980; Luciani et al., 1979),
its genetic activity could depend on the
interaction of intracellularly reduced
Cr(III) with specific targets on the DNA
molecule (Levis et al., 1978a,b; Norseth,
1979; Langard, 1980; Petrilli & De Flora,
1-980; Bianchi et al., 1980; Leonard &
Lauwerys, 1980). Interactions with nucleic
acids, giving changes of their physico-
chemical and biochemical properties
which could be relevant to the production
of genetic changes, have been shown to
occur both when purified nucleic acids are
treated in vitro with Cr(III) compounds
(Sirover & Loeb, 1976; Tamino & Peretta,
1980; Tkeshelashvili et al., 1980: Tamino
et al., 1981) and when cells are treated
with Cr(VI) compounds (Whiting et al.,
1979; Douglas et al., 1980; Tamino et al.,
1981). Owing to the stability of Cr(III)
chelates and coordination complexes and
to their very low exchange rate with
biological ligands (Mertz, 1969; Norseth,
1979; Langard, 1980; Petrilli & De Flora,
1980), the crucial site for the expression
of Cr(VI) (carcino) genetic activity should
be where Cr(VI) is converted to Cr(III).
Only Cr(VI) reduction within the cell
nucleus, and then only in the cells of
target organs, could produce the inter-
action of Cr(III) with biological molecules
relevant for the expression of carcinogenic
effects. It is generally assumed that Cr
exists within cells only in its reduced
form, and Cr(III) is indeed detected, even
after treatment with Cr(VI) compounds,
by colorimetry (Levis et al., 1978a, b; and
in the present data), atomic absorption
spectrophotometry (Feldman et al., 1967)
and gas chromatography (Savory et al.,
1970). All these procedures, however,
require wet decomposition of the bio-
logical samples with acidic mixtures which,
in our experience, produce significant
reduction of Cr(VI) to Cr(III) (see
Methods). So we cannot exclude the possi-
bility that limited amounts of Cr(VI), not
reduced within the cytoplasm, reach the
cell nucleus and react there with the DNA
targets. The existence of Cr(VI) within
root cells treated with potassium chromate
has been demonstrated by Skeffington
et al. (1976) by high-voltage paper electro-
phoresis.
It is noteworthy that Cr(VI) muta-
genicity is decreased and even suppressed
by the rat liver microsomal fraction,
erythrocyte lysates, human gastric juice
(Petrilli & De Flora, 1978a; Lofroth, 1978;
De Flora & Boido, 1980; De Flora, 1978)
and through reduction to Cr(III) by
simpleoxidoreduction, but it is not reduced
by the microsomal fraction from rat
muscle (Petrilli & De Flora, 1978a) and it
is partially reduced by the microsomal
preparations from rat lung, though far less
efficiently than by the corresponding liver
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preparations (Petrilli & De Flora, 1980).
These observations correlate quite well
with the preferential localization of Cr-
induced cancers in the human lung, with
the lack of Cr(VI) oral carcinogenicity,
with the development of tumours at
implant sites (e.g. respiratory tract and
muscles) in rodents treated with Cr(VI)
compounds, and with the lack of carcino-
genicity of Cr(III) compounds (IARC
1980). Therefore only in the simplified
in vitro test systems, where Cr(VI) is
stable during long incubations (Bianchi
et al., 1979; Umeda & Nishimura, 1979)
and in the cells of in vivo target organs
such as lungs and muscles, where Cr(VI)
is not reduced by the microsomal fraction,
could oxidized Cr(VI) reach the cell
nucleus where it could be reduced to
Cr(I1) on or near the critical target
molecules. The very active conversion of
Cr(VI) to Cr(1JJ) by erythrocytes (Lan-
gard, 1980) and by the microsomal frac-
tion ofliver cells (De Flora, 1978; Lofroth,
1978; Petrilli & De Flora, 1978a) repre-
sents an important mechanism of Cr(VI)
inactivation in the organism.
Only chromates of medium (Ca chro-
mate, Zn chromate hydroxide) or low
(Sr and Pb chromates) water solubility,
but not the very soluble Na and K chro-
mates and dichromates, are carcinogenic
in animals (IARC, 1980) but in vitro
chromates and dichromates of high solu-
bility have proved to be potent cytotoxic
and mutagenic agents (see above referen-
ces). The obvious explanation for the
lack of carcinogenicity of high-solubility
chromates is that, even though they may
be potential mutagens, they disappear
from the site of application very rapidly,
and are eventually inactivated by erythro-
cytes (Langard, 1980). In in vitro condi-
tions we can keep compounds in the cul-
ture medium for a few days without dilu-
tion or inactivation. On the other hand
lead chromate, which is known to be a
fairly potent carcinogen (IARC, 1980),
was shown to induce point mutations in
bacteria when solubilized in acids and
alkalis (Nestmann et al., 1979; De Flora,
1981), but it was inactive as a mutagen
for bacteria and mammalian cells in
culture when used as a fine suspension in
water (Newbold et al., 1979; De Flora,
1981). In view of the very low water
solubility of this compound and the rela-
tively short exposure in the in vitro experi-
ments, their negative result is not sur-
prising, neither it is in conflict with the
positive carcinogenicity tests where the
period of exposure is much longer and the
material persists at the site of application
so that significant exposure of cells to
chromate ions from Pb chromate would be
expected.
The state of oxidation is certainly the
most important parameter to be taken
into account when considering the bio-
logical activity of chromium compounds,
but other properties, such as the solubility
in water, the ability to permeate cell
membranes and the intracellular stability
of the oxidized Cr(VI) form (determining
different retention and diffusion rates in
vivo and in vitro) are relevant in producing
differential effects in long-term carcino-
genicity and short-term mutagenicity
tests. Although there are still definite
gaps in our understanding of the relation-
ships between chromium mutagenicity
and carcinogenicity, and the exact roles
ofsoluble and insoluble Cr(VI) and Cr(III)
compounds in carcinogenesis, the know-
ledge of the mutagenic, cytogenetic and
cytotoxic powers of Cr(VI) and Cr(III)
compounds is already sufficient for assess-
ing their respective contributions as
human hazards.
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